SEC Form 4 · accession 0001179110-18-011959
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Sep 28, 2018 | S | 1,532 | $73.351 | D | 39,229 | D | |
| Common shares without par value | Sep 28, 2018 | S | 100 | $73.3501 | D | 39,129 | D | |
| Common shares without par value | Sep 28, 2018 | S | 100 | $73.355 | D | 39,029 | D | |
| Common shares without par valueF1 | holding | — | — | — | 753 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of September 28, 2018.